Project Grant HT94252310016
Award Date
1/1/23
Completion Date
12/31/24
Dollars Obligated
$311K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
The U.S. Defense Health Agency awarded a $1,965,204 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Washington to support the early-stage development of an anti-inflammatory melanocortin fusion protein for tactical combat casualty care. The award period runs from August 1, 2024 to July 31, 2027. This research aims to investigate new therapeutic approaches for improving health outcomes for military service members. As a prominent...
The University of Washington was awarded a $1,810,550 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 through September 30, 2026 to investigate early chemodenervation of the detrusor muscle to preserve bladder compliance and function over the long term following spinal cord injury. The Military Medical Research and Development program supports basic,...
The University of Washington received a $617,221 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant funds research to advance the efficacy, longevity, and safety of gene editing therapies for Duchenne muscular dystrophy (DMD). The 2-year grant period runs from August 15, 2023 to August 14, 2025. As a leading research institution, the University of Washington has previously received federal funding to support a...
The Defense Health Agency awarded Texas A&M University System Health Science Center a $303,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research on Potential-Independent Mitochondrial Targeting from February 15, 2023 through August 31, 2025. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative solutions. This award will allow the...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
The University of Washington received a $622,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the fibrolamellar carcinoma tumor microenvironment using human tumor slice cultures. The award has a performance period from July 1, 2024 to June 30, 2026. Through this funding, the University of Washington will investigate innovative approaches to improve understanding of the fibrolamellar carcinoma tumor...
The federal Project Grant award of $932,918 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research at the University of Washington to determine the role of somatic mosaicism in ovarian cancer predisposition. The grant, awarded on September 30, 2024 with an ultimate completion date of September 29, 2028, will enable the University of Washington to conduct innovative scientific studies to improve health outcomes for military...
The University of Washington will receive $749,915 from the Defense Health Agency through September 2023 to August 2027 under the Military Medical Research and Development federal grant program (CFDA 12.420). The funding will support the university's project to enhance the efficacy of androgen receptor antagonist therapy with tumor necrosis factor-alpha blockade in metastatic prostate cancer. The Military Medical Research and Development program aims to transform military and public health...
The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
The Department of the Army Medical Command awarded a $2.4 million Project Grant to the University of Washington under the Military Medical Research and Development program (CFDA 12.420) to support research titled "Precision Nutrition Increases Efficacy of DNA-Damaging Therapies in Prostate Cancer." The four-year award, effective September 1, 2022 through August 31, 2026, will fund research investigating medical solutions for the battlefield by exploring how precision nutrition can...